Media stories about LivaNova PLC (NASDAQ:LIVN) have been trending positive this week, according to Accern Sentiment. Accern scores the sentiment of media coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. LivaNova PLC earned a news impact score of 0.26 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.11425633742 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Here are some of the news articles that may have impacted Accern Sentiment’s rankings:
- LivaNova PLC (LIVN) Lifted to Buy at Needham & Company LLC (americanbankingnews.com)
- LivaNova PLC (LIVN) PT Raised to $80.00 (americanbankingnews.com)
- LivaNova PLC (LIVN) Upgraded at Needham & Company LLC (americanbankingnews.com)
- LivaNova Defines Strategic Outlook at Investor Day (finance.yahoo.com)
- LivaNova to Explore Strategic Options for Cardiac Rhythm Management Business Franchise (finance.yahoo.com)
A number of analysts have recently weighed in on the stock. BidaskClub lowered shares of LivaNova PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Jefferies Group LLC increased their price target on shares of LivaNova PLC from $76.00 to $80.00 and gave the stock a “buy” rating in a research note on Friday. Needham & Company LLC raised shares of LivaNova PLC from a “hold” rating to a “buy” rating and set a $83.00 price target for the company in a research note on Friday. Berenberg Bank reaffirmed a “buy” rating and set a $70.00 target price on shares of LivaNova PLC in a research note on Friday, August 11th. Finally, Piper Jaffray Companies reaffirmed an “overweight” rating and set a $75.00 target price on shares of LivaNova PLC in a research note on Tuesday, September 12th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have given a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $68.67.
Shares of LivaNova PLC (NASDAQ:LIVN) opened at 68.42 on Friday. The company has a market capitalization of $3.34 billion, a P/E ratio of 122.18 and a beta of 0.58. The stock’s 50 day moving average is $62.55 and its 200 day moving average is $57.59. LivaNova PLC has a 12 month low of $40.83 and a 12 month high of $69.29.
LivaNova PLC (NASDAQ:LIVN) last posted its quarterly earnings data on Wednesday, August 9th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.82 by $0.19. The business had revenue of $321.40 million for the quarter, compared to the consensus estimate of $315.75 million. LivaNova PLC had a net margin of 2.26% and a return on equity of 9.08%. The firm’s revenue was up .1% on a year-over-year basis. On average, equities analysts predict that LivaNova PLC will post $3.24 EPS for the current fiscal year.
In related news, Director Daniel Jeffrey Moore sold 1,000 shares of the firm’s stock in a transaction dated Monday, July 17th. The shares were sold at an average price of $61.55, for a total transaction of $61,550.00. Following the completion of the sale, the director now directly owns 56,437 shares in the company, valued at $3,473,697.35. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.28% of the stock is owned by corporate insiders.
About LivaNova PLC
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.